Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 4 minute read Pharma Industry News Clover Biopharmaceuticals receives FDA clearance for RSV vaccine trial, expands respiratory disease research Clover Biopharmaceuticals advances RSV vaccine research with FDA-approved SCB-1019 trials, targeting revaccination gaps and combination immunization strategies. byPallavi MadhirajuMarch 24, 2025